← Leaderboards
Staci L Sudenga
Vanderbilt University Medical Center
$921,262
Attributed
$921,262
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $148.5K · FY2016–22$200K$150K$100K$50K$0
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$921,262 · 2
By mechanism
K07$742,285 · 1
R03$178,977 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University Medical Center
Same institution · by research overlap
- Kristen Keon Ciombor$1,859,641
- Ravi Shah$14,155,608
Others in their field
Top investigators on “Publishing”
- Constance Ann Benson · University Of California, San Diego$243,271,751
- Richard K. Wilson · Washington University$201,137,538
- Norman Wolmark · Nsabp Foundation, Inc.$139,047,706
- Judith S. Currier · University Of California Los Angeles$137,892,773
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$137,892,773
- Peter C Adamson · National Childhood Cancer Foundation$108,407,802
Research focus
PublishingWomanInnovationProspectiveSpecimenUnited StatesHuman PapillomavirusInfectionMalignant Neoplasm Of Cervix UteriProgramsResourcesAnusArchivesCd8b1 GeneFundingHigh RiskHuman Papilloma Virus InfectionIncidenceLeadLesionNatural HistoryPositioning AttributeCellsArea
Grant awards (7)
Tumor-Infiltrating Lymphocytes in Anal Cancer and Pre-malignant Anal Lesions$148,457
K07 · FY2022 · CA · contact PI
Tumor-Infiltrating Lymphocytes in Anal Cancer and Pre-malignant Anal Lesions$148,457
K07 · FY2021 · CA · contact PI
Tumor-Infiltrating Lymphocytes in Anal Cancer and Pre-malignant Anal Lesions$148,457
K07 · FY2020 · CA · contact PI
Tumor-Infiltrating Lymphocytes in Anal Cancer and Pre-malignant Anal Lesions$148,457
K07 · FY2019 · CA · contact PI
Tumor-Infiltrating Lymphocytes in Anal Cancer and Pre-malignant Anal Lesions$148,457
K07 · FY2018 · CA · contact PI
The risk of HIV seroconversion following an HPV infection among men$80,265
R03 · FY2017 · AI · contact PI
The risk of HIV seroconversion following an HPV infection among men$98,712
R03 · FY2016 · AI · contact PI